Connect with us

Hi, what are you looking for?

Editor's Pick

Psychedelic Legalization

Peter Van Doren

drug treatment

New Zealand recently took a baby step toward the use of psychedelics to treat depression, post-traumatic stress disorder, and substance abuse by allowing one and only one psychiatrist to prescribe psilocybin, the hallucinogen found in “magic mushrooms.” For an update on the status of legalization in the United States, see this article in the summer issue of Regulation

In August 2024, the Food and Drug Administration rejected the first application for federally approved psychedelic therapy. But innovation is occurring at the state level. Oregon’s 2020 Psilocybin Services Act and Colorado’s 2022 Natural Medicine Health Act provide early blueprints. New Mexico has recently enacted its own medicinally focused psychedelic reform law as well.

We do not need to wait for the FDA.

You May Also Like

Editor's Pick

Take a tour of the FIVE latest updates and additions to our fan-favorite, professionally-curated Market Summary dashboard with Grayson! In this video, Grayson walks...

Editor's Pick

MACD, ADX and S&P 500 action frame Joe Rabil’s latest show, where a drifting index push him toward single-stock breakouts. Joe spotlights the daily...

Editor's Pick

The S&P 500 ($SPX) just logged its second consecutive 1% gain on Tuesday. That’s three solid 1% advances so far in June. And with...

Editor's Pick

Over a month ago, Super Micro Computer, Inc. (SMCI) appeared on our StockCharts Technical Rank (SCTR) Top 10 list. SCTRs are an exclusive StockCharts...